![Lonnie Moulder](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von Lonnie Moulder
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Helsinn Holding SA
![]() Helsinn Holding SA Hospital/Nursing ManagementHealth Services Helsinn Holding SA is a holding Swiss company that provides cancer services through its subsidiaries. The private company is based in Lugano, Switzerland and has subsidiaries in Switzerland and Ireland. The company was founded in 1976 by Gabriele Edoardo Braglia. Riccardo Braglia has been the CEO of the company since 2002.
7
| Private Company | Hospital/Nursing Management | 7 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Lonnie Moulder
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Helsinn Healthcare SA
![]() Helsinn Healthcare SA Pharmaceuticals: MajorHealth Technology Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Founder Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Helsinn Therapeutics (U.S.), Inc.
![]() Helsinn Therapeutics (U.S.), Inc. Pharmaceuticals: MajorHealth Technology Helsinn Therapeutics (U.S.), Inc. develops, manufactures and supplies pharmaceutical products for treatment of cancer. The company is headquartered in Iselin. NJ. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Helsinn Birex Pharmaceuticals Ltd.
![]() Helsinn Birex Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Helsinn Birex Pharmaceuticals Ltd. develops and manufactures oral dosage drug products. It is engaged in providing oral solid dosage forms and topical forms of pharmaceutical products and packaging of sterile products. The firm supplies its partners with ready to sell products on an exclusive basis, which are manufactured on site and using a network of external manufacturing partners. The company was founded by Gabriele Braglia on May 18, 1978 and is headquartered in Dublin, Ireland. | Pharmaceuticals: Major | Chairman Founder | |
Helsinn Healthcare SA /Venture/
![]() Helsinn Healthcare SA /Venture/ Investment ManagersFinance 3B FUTURE HEALTH VENTURES SARL (3B Future Health Ventures) is a venture capital subsidiary of Helsinn Healthcare SA founded in 2016. The firm is headquartered in Monaco, Luxembourg. | Investment Managers | Chairman Private Equity Investor | |
BSP Pharmaceuticals SpA
![]() BSP Pharmaceuticals SpA Pharmaceuticals: MajorHealth Technology BSP Pharmaceuticals SpA develops and manufactures anticancer drugs. It offers development, clinical supply, commercial supply, and analytical services. The company was founded by Aldo Braca in July 2006 and is headquartered in Latina Scalo, Italy. | Pharmaceuticals: Major | Director/Board Member | |
Cell Therapy Ltd.
![]() Cell Therapy Ltd. BiotechnologyHealth Technology Cell Therapy Ltd. produces regenerative medicines using adult stem cells to treat heart failure. Its product HeartCel, a stem cell therapy that offers improved outcomes for heart failure patients by reducing the size of heart scar, improving heart function, quality of life and reducing mortality. The firm develops therapies based on the adult mesenchymal stromal cells technology platform. The firm’s regenerative therapies will focus on curing the cause of the disease, rather than only treating the symptoms. The company was founded in 2009 by Martin John Evans and Ajan Trevor Reginald and is headquartered in Cardiff, the United Kingdom. | Biotechnology | Director/Board Member | |
Quanta Dialysis Technologies Ltd.
![]() Quanta Dialysis Technologies Ltd. Medical SpecialtiesHealth Technology Quanta Dialysis Technologies Ltd. develops haemodialysis systems. The firm's SC+ is a performance, portable, compact haemodialysis system providing clinical efficacy utilising flow rates typically used on traditional machines. It offers SelfCare+, a haemodialysis machine for dialysis patients to control their disease and determine the treatment regime and care. The company was founded by Clive Henrey Buckberry, John Eric Milad and Martin Johnson in 2008 and is headquartered in Alcester, the United Kingdom. | Medical Specialties | Director/Board Member | |
European Federation of Pharmaceutical Industries & Assns
![]() European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Italfarmaco SpA
![]() Italfarmaco SpA Pharmaceuticals: MajorHealth Technology Italfarmaco SpA engages in the production and distribution of pharmaceutical and fine chemical products. It also provides research and development, scientific publishing, business development, and licensing services. The company was founded in 1938 and is headquartered in Milan, Italy. | Pharmaceuticals: Major | Director/Board Member | |
NIOX GROUP PLC | Medical/Nursing Services | Chairman | |
University of Pavia | College/University | Doctorate Degree | |
Prismic Pharmaceuticals, Inc.
![]() Prismic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prismic Pharmaceuticals, Inc. engages in the research and development of prescription drugs for kidney disease, mental health, and chronic pain. It also offers medical foods for patients with chronic kidney disease, and depression and bipolar disorder. The company was founded by Zachary Dutton, Danilo Casadei Massari, and Peter J. Moriarty in 2011 and is headquartered in Worcester, MA. | Pharmaceuticals: Major | Director/Board Member | |
Warburg Pincus International LLC | Investment Managers | Private Equity Investor | |
BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
New York Philharmonic
![]() New York Philharmonic Movies/EntertainmentConsumer Services New York Philharmonic provides live theatrical presentations. The company was founded in 1842 and is headquartered in New York, NY. | Movies/Entertainment | Consultant / Advisor | |
Fondazione per la ricerca sul cancro nel Ticino | Director/Board Member | ||
3B Future Health Fund II S.C. A. SICAV-RAIF
![]() 3B Future Health Fund II S.C. A. SICAV-RAIF Investment ManagersFinance 3B Future Health Fund II S.C. A. SICAV-RAIF invests in companies located in the US, Europe, Israel and Japan. The fund target companies operating in the fields of healthcare. It provides financing for early stage capital requirements with an investment up to USD 12 million. It also makes follow on investment and take a seat on the board of director. | Investment Managers | Chairman | |
Biogen Idec, Inc. (North Carolina)
![]() Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Pharmacia & Upjohn SpA | Corporate Officer/Principal | ||
Schering-Plough Corp.
![]() Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Novartis Pharma AG
![]() Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
INTERROLL HOLDING AG | Industrial Machinery | Director/Board Member | |
FINANCIÈRE DE TUBIZE S.A. | Financial Conglomerates | Director/Board Member | |
Fej SRL
![]() Fej SRL Financial ConglomeratesFinance Fej SRL provides financial services. The private company is based in Brussels, Belgium. The Belgian company was founded in 1995. | Financial Conglomerates | Director/Board Member | |
Abionic SA
![]() Abionic SA Medical SpecialtiesHealth Technology Abionic SA develops biomedical diagnostic devices. It specializes in in vitro diagnostic devices for allergies detection. The firm?s products include abioSCOPE and abioKIT. Its services encompass research, development, and commercialization of its products. The company was founded by Nicolas Durand, Iwan M?rki, and Theo Lasser in 2010 and is headquartered in Lausanne, Switzerland. | Medical Specialties | Director/Board Member | |
A. Menarini Industrie Farmaceutiche Riunite SRL
![]() A. Menarini Industrie Farmaceutiche Riunite SRL Pharmaceuticals: MajorHealth Technology A. Menarini Industrie Farmaceutiche Riunite SRL operates as a pharmaceutical company. It specializes in the research, development, and marketing of products for therapy and wellness, diagnostics, and biotechnology. The company was founded in 1886 and is headquartered in Florence, Italy. | Pharmaceuticals: Major | Chairman | |
Novartis International AG
![]() Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Compliance Officer | |
Novartis Pharma BV | Corporate Officer/Principal | ||
Novartis Pharma SAS
![]() Novartis Pharma SAS Pharmaceuticals: MajorHealth Technology Novartis Pharma SAS wholesales and distributes pharmaceutical products. It offers generic and branded drugs and medicines. The company is headquartered in Rueil-Malmaison, France. | Pharmaceuticals: Major | Chairman | |
STADA ARZNEIMITTEL | Pharmaceuticals: Major | Director/Board Member | |
Gui Sheng Tang Sinomedica Holding SA | Director/Board Member | ||
University of California, Berkeley | College/University | Graduate Degree | |
University of Basel | College/University | Doctorate Degree | |
NOVARTIS AG | Pharmaceuticals: Major | Compliance Officer | |
Swiss Federal Institute of Technology | College/University | Doctorate Degree | |
FSI SGR SpA
![]() FSI SGR SpA Investment ManagersFinance FSI SGR SpA (FSI) also known as Fondo Strategico Italiano, is an independent private equity firm. The firm was founded in 2016 and is headquartered in Milan, Italy. | Investment Managers | Private Equity Investor | |
UTILITY therapeutics Ltd.
![]() UTILITY therapeutics Ltd. Pharmaceuticals: GenericHealth Technology Utility Therapeutics Ltd. is a British company that has exclusive US commercial rights to two European-approved antibiotics, mecillinam and an oral prodrug of mecillinam, for the treatment of urinary tract infections (UTI). The private company is based in Altrincham, UK and was founded in 2018 by Rasmus Toft-Kehler, Morten Otto Alexander Sommer, Peter Aksel Villadsen. Mecillinam is being developed as a first-line therapy for complicated UTI in the hospital setting, while the oral prodrug is being developed for uncomplicated UTI. The company has received the FDA's Qualified Infectious Disease Product (QIDP) designation for the treatment of UTI. Utility Therapeutics is committed to developing antibiotics that meet urgent treatment needs for multi-drug resistant infections. | Pharmaceuticals: Generic | Director/Board Member | |
Diadem SpA
![]() Diadem SpA Miscellaneous Commercial ServicesCommercial Services Diadem Srl predicts, monitors, diagnosis and drug development for Alzheimer?s disease. focuses on specific research on early peripheral markers of Alzheimer's disease into technology. The company was founded by Maurizio Memo and Daniela Uberti in June 2012 and is headquartered in Brescia, Italy. | Miscellaneous Commercial Services | Director/Board Member | |
Micromega Ltd.
![]() Micromega Ltd. Miscellaneous Commercial ServicesCommercial Services Micromega Ltd. provides business support services. The private company is based in London, UK. The British company was founded by Francesco Granata. | Miscellaneous Commercial Services | Founder | |
Kyowa Kirin International Plc
![]() Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Lauro & Giavatto SA | President | ||
Fondazione Nuovo Fiore in Africa | Founder | ||
Helsinn SA | Chairman | ||
BLUEBIRD BIO, INC. | Biotechnology | Director/Board Member | |
The American Association of Immunologists | Corporate Officer/Principal | ||
Women Innovating Together In Healthcare
![]() Women Innovating Together In Healthcare Miscellaneous Commercial ServicesCommercial Services Women Innovating Together In Healthcare operates as an organization of accomplished women. The private company is based in Paris, France. The French company was founded by Rafaèle Elisabeth Tordjman. | Miscellaneous Commercial Services | Director/Board Member |
Statistik
International
Schweiz | 13 |
Vereinigte Staaten | 13 |
Italien | 8 |
Vereinigtes Königreich | 8 |
Belgien | 4 |
Sektoral
Health Technology | 25 |
Finance | 8 |
Consumer Services | 6 |
Commercial Services | 5 |
Health Services | 2 |
Operativ
Director/Board Member | 57 |
Corporate Officer/Principal | 19 |
Chairman | 12 |
Founder | 8 |
Independent Dir/Board Member | 7 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Lonnie Moulder
- Unternehmensverbindungen